Assessment of the impact of subcutaneous catheter change on glucose control in patients with type 1 diabetes treated by insulin pump in open- and automated insulin delivery modes
Jean-Baptiste Julla,Pauline Jacquemier,Elisabeth Bonnemaison,Guy Fagherazzi,Helene Hanaire,pauline schaepelynck,Mihaela Mihaileanu,Eric Renard,yves reznik,Jean-Pierre Riveline
DOI: https://doi.org/10.1089/dia.2023.0568
2024-02-14
Diabetes Technology & Therapeutics
Abstract:Introduction Most continuous subcutaneous insulin infusion (CSII) catheters (KT) are changed every 3 days. This study aims at evaluating whether KT changes impact glucose control while under open-loop (OL) or automated insulin delivery (AID) modes. Methods We included patients with type 1 diabetes (T1D) who used Tandem t:slim x2 insulin pump and Dexcom G6 glucose sensor for 20 days in OL, then as AID. CSII and sensor glucose data in OL and for the last 20 days of 3-month AID were retrospectively analyzed. The percentage of time spent with sensor glucose above 180 mg/dL (%TAR180) was compared between the calendar day of KT change (D0), the next day (D1) and two days later (D2). Values were adjusted for age, sex, body mass index (BMI), HbA1c at inclusion and %TAR180 for the 2h before KT change. Results A total of 1636 KT changes was analyzed in 134 patients: 72 women (54%), age: 35.6±15.7 years, BMI: 25.2±4.7 kg/m2, HbA1c: 7.5±0.8 %. %TAR180 in the 2h before the KT change was 51.3±37.0% in OL and 33.2±30.0% in AID mode. In OL, significant increases of %TAR180 at D0 vs. D1 (+6.9%;p<0.0001) or vs. D2 (+6.8%;p<0.0001) were observed. In AID, significant increases of %TA180R at D0 vs. D1 (+4.8%;p<0.0001) or vs. D2 (+4.2%;p<0.0001) were also observed. Conclusion This study shows an increase in time spent in hyperglycemia on the day of the KT change both in OL and AID modes. This additional information should be taken into account to improve current AID algorithms.
endocrinology & metabolism
What problem does this paper attempt to address?